Galderma launches ALASTIN Restorative Eye Complex with TriHex+™, bringing new science-backed innovation to the entire eye area
- Restorative Eye Complex is now formulated with TriHex+™, which pairs ALASTIN's TriHex Technology® to support the body’s natural processes for collagen and elastin production with proprietary Octapeptide-45 and the skin's natural ability to boost its own high-molecular-weight HA for visible plumping and hydration.¹
- The enhanced formulation further supports the appearance of skin firmness, elasticity, lift, and barrier through the addition of Acetyl Tetrapeptide-2 and a proprietary dill and blackberry blend.¹
- Developed to address the full eye area, including crow's feet, the under-eye area and the often-overlooked upper eyelid, Restorative Eye Complex showed statistically significant improvement in the appearance of crow's feet fine lines, under-eye puffiness and upper-eyelid fine lines at Week 12, based on investigator grading in a clinical evaluation of 29 patients.²
- Restorative Eye Complex is the third product launched with ALASTIN's innovative TriHex+™ technology, further expanding the brand's TriHex+ portfolio.
Zug, Switzerland – October 26, 2026 – Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the U.S. launch of ALASTIN Restorative Eye Complex with TriHex+™, a meaningful advancement of a trusted ALASTIN product. The new formula brings ALASTIN’s TriHex+™ platform to a product developed to address visible signs of aging across the entire eye area, including the upper eyelid, under-eye and crow’s feet.
Visible signs of aging around the eyes can appear in several places at once: creasing on the upper eyelid, fine lines at the outer corners and puffiness beneath the eyes. Restorative Eye Complex with TriHex+™ was developed with these distinct areas in mind, targeting the underlying biology of visible skin aging around the eyes, with clinically evaluated improvements in each area.
At the foundation of the enhanced formula is TriHex+™, which combines ALASTIN’s TriHex Technology® with proprietary Octapeptide-45. TriHex™ supports the body’s natural collagen and elastin production, while Octapeptide-45 helps the skin’s ability to naturally increase its own production of high-molecular-weight HA for visible plumping and hydration benefits.¹
Around the eyes, TriHex+™ helps renew surface structure, supporting dermal-epidermal junction (DEJ) integrity and natural high-molecular-weight HA. It also helps refine contour by softening the visible transition from the lower eyelid to the cheek, including reduction in dark circles, hollowing and puffiness.¹
The formula also includes Acetyl Tetrapeptide-2, which supports lift. A proprietary dill and blackberry blend further supports natural elastin and protection to help maintain firmer-looking skin. Together with TriHex+™, the blend works to maintain DEJ integrity, helping the formula visibly smooth, hydrate and strengthen¹ the delicate eye area. These new technologies join the formula’s trusted foundation of mimosa tree extract, oak and green tea leaf extracts, niacinamide and the original TriHex Technology®.
“Our work has always focused on amplifying the skin’s natural ability to regenerate itself, rather than simply covering up the signs of aging. The skin around the eyes is thin and delicate, and it depends on collagen, elastin, and hyaluronic acid to stay firm and hydrated. With TriHex+™, we're helping the skin with all three. And by addressing the upper eyelid, under-eye and crow's feet individually, we can deliver meaningful, visible results in each of these key areas.”
ALAN D. WIDGEROW, MBBCH, MMED, FCS, FACS
CHIEF SCIENTIFIC OFFICER, GALDERMA
HEAD, SKIN SCIENCE CENTER FOR INNOVATION
The enhanced formula was assessed in a large, robust clinical evaluation of 29 patients aged 35 to 70 with moderate-to-severe signs of aging around the eyes. The upper eyelid, lower eyelid and crow’s feet areas were evaluated separately using investigator clinical grading, clinical photography, subject self-assessment, and hydration and elasticity instrumentation.²
At Week 12, investigator clinical grading showed a significant 30.13% improvement in crow’s feet fine lines and a 33.63% improvement in under-eye puffiness (p<0.0001 for both), and a substantial 21.62% decrease in upper-eyelid fine lines (p<0.0001).² For study participants, this translated to visibly reduced puffiness and a more refined lower-eye contour for a less tired look, along with a softened appearance of fine lines around the crow's feet and smoother-looking wrinkles along the upper-eyelid crease.
"When patients express concern that their eyes look tired, they are often describing a combination of changes, including under-eye puffiness, fine lines, and changes in the upper eyelids. As these concerns can affect different areas around the eyes, I wanted to better understand what matters most to patients and evaluate an approach that addresses the eye area comprehensively. Restorative Eye Complex with TriHex+™ was developed with those considerations in mind, and the compelling clinical research provides encouraging evidence of improvement across multiple areas of concern.”
DR. BRIAN BEISMAN, M.D., F.A.C.S.
BOARD-CERTIFIED OCULOFACIAL PLASTIC SURGEON
For patients concerned about under-eye hollows, providers can also pair Restorative Eye Complex with TriHex+™ with in-office treatments such as Restylane® Eyelight™, an FDA-approved hyaluronic acid filler for the improvement of infraorbital hollows.
Restorative Eye Complex with TriHex+™ joins Regenerating Skin Nectar and Restorative Skin Complex in ALASTIN’s TriHex+™ portfolio.
Restorative Eye Complex with TriHex+™ will initially be available exclusively in the U.S. through authorized healthcare providers and provider microsites. To find a provider near you, visit www.alastin.com/pages/provider-locator.
About ALASTIN
ALASTIN by Galderma is the leader in peri-procedural regenerative skincare, offering innovative, scientifically proven, and clinically tested products. The ALASTIN Skincare portfolio provides a comprehensive collection of cutting-edge formulas designed specifically for peri-procedural use, as well as daily skincare regimens, all powered by proprietary peptides and innovative, clinically meaningful, science-backed ingredients designed to amplify the skin’s own natural regenerative abilities. With more than 60 international dermatological publications and 25 patents granted, ALASTIN is one of the most clinically studied professional-grade skincare brands.
About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.
For further information:
Christian Marcoux, M.Sc. Chief Communications Officer christian.marcoux@galderma.com +41 76 315 26 50 | Emil Ivanov Head of Strategy, Investor Relations, and ESG +41 21 642 78 12 |
Viviana Wiewall Head of U.S. Communications +1 786 451 7740 | Jessica Cohen Investor Relations and Strategy Director +41 21 642 76 43 |
Céline Buguet Franchises and R&D Communications Director +41 76 249 90 87 |
|
References
ALASTIN data on file.
ALASTIN data on file. Clinical evaluation of Restorative Eye Complex with TriHex+™ in 29 patients aged 35–70 with moderate-to-severe periocular concerns. Investigator clinical-grading findings at Week 12.